Adaptyx raises $14M to support multi-analyte monitoring biowearable
Adaptyx Biosciences announced today that it raised $14 million in seed funding to support its multi-analyte molecular monitoring device.
The seed round brings its total funding to $23 million since inception in 2022. Interlagos led the round with significant participation from Overwater Ventures. Starbloom Capital, Stanford University, the Chan Zuckerberg Biohub, Hyperlink Ventures, Cantos Ventures, Humba Ventures and Seaside Ventures all participated, too.
Adaptyx develops a biowearable platform aiming to redefine continuous health monitoring. The company designed its patch device to move beyond glucose and capture a much wider range of human biochemistry. That includes small molecules, electrolytes, hormones, drugs and proteins.
The device pairs continuous molecular sensing with AI-powered analytics to transform data into actionable insights. Its Molecular Switch Foundry accelerates biosensor development by integrating automated molecular design, parallelized screening and AI-driven optimization. It aims to compress development timelines from years to just weeks.
